PerfuseCell Cronus A/S: Financial statements 2013
CVR: 31606810
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 2,566 and a net result of DKK -631 compared with DKK -44,956 the year before. The profit margin was -24.6%. Equity in the 2013 report amounted to DKK 17,115. The solvency ratio was 100%.
- Revenue
- DKK 2,566
- Gross Profit
- DKK 2,566
- Profit/Loss
- DKK -631
- Equity
- DKK 17,115
- Total Assets
- DKK 17,115
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 3 t. | 3 t. | -631 | 17 t. | - |
| 2012 | - | -45 t. | -45 t. | 18 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PerfuseCell Cronus A/S has published its annual report for 2012. Gross profit came to DKK -44,995, and the net result was DKK -44,956.
As of May 6, 2013, Din Revisor Lyngby A/S Godkendte Revisorer has stepped down as auditor of PerfuseCell Cronus A/S.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.